Cargando…

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment

ADAM (a disintegrin and metalloproteinase) is a family of widely expressed, transmembrane and secreted proteins of approximately 750 amino acids in length with functions in cell adhesion and proteolytic processing of the ectodomains of diverse cell-surface receptors and signaling molecules. ADAM10 i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peron, Rafaela, Vatanabe, Izabela Pereira, Manzine, Patricia Regina, Camins, Antoni, Cominetti, Márcia Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874708/ https://www.ncbi.nlm.nih.gov/pubmed/29382156 http://dx.doi.org/10.3390/ph11010012

Ejemplares similares

ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer’s Disease
por: Pereira Vatanabe, Izabela, et al.
Publicado: (2021)

Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms
por: Endres, Kristina, et al.
Publicado: (2017)

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
por: Agüero, Pablo, et al.
Publicado: (2020)

Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
por: Poor, Saghar Rabiei, et al.
Publicado: (2021)

ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study
por: Oliveira Monteiro, Maria Patrícia A., et al.
Publicado: (2021)

The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by α-secretase ADAM10
por: Hitschler, Lisa, et al.
Publicado: (2022)

S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10
por: Qin, Weiping, et al.
Publicado: (2009)

Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10
por: Augustin, Regina, et al.
Publicado: (2012)

Repression of Alzheimer's beta-Secretase
por: Liao, Francesca-Fang, et al.
Publicado: (2013)

γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022)

Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
por: Ettcheto, Miren, et al.
Publicado: (2020)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2018)

The role of ADAM10 in astrocytes: Implications for Alzheimer’s disease
por: Elsworthy, Richard J., et al.
Publicado: (2022)

Determination of the Proteolytic Cleavage Sites of the Amyloid Precursor-Like Protein 2 by the Proteases ADAM10, BACE1 and γ-Secretase
por: Hogl, Sebastian, et al.
Publicado: (2011)

Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/γ-secretase activity
por: Riedle, Svenja, et al.
Publicado: (2009)

The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer’s disease
por: Musardo, Stefano, et al.
Publicado: (2022)

Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of γ-secretase in renal carcinoma
por: Guo, Zhen, et al.
Publicado: (2013)

Cognitive rehabilitation: Literature review based on levels of evidence
por: Manzine, Patricia Regina, et al.
Publicado: (2009)

Comorbidities predict 30-day hospital mortality of older adults with COVID-19
por: Pott Junior, Henrique, et al.
Publicado: (2021)

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
por: Folch, Jaume, et al.
Publicado: (2018)

Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
por: Ettcheto, Miren, et al.
Publicado: (2021)

Role of ADAM10 and ADAM17 in Regulating CD137 Function
por: Seidel, Jana, et al.
Publicado: (2021)

Caspr1 Facilitates sAPPα Production by Regulating α-Secretase ADAM9 in Brain Endothelial Cells
por: Tang, Shi-Yu, et al.
Publicado: (2020)

β-Secretases, Alzheimer's Disease, and Down Syndrome
por: Webb, Robin L., et al.
Publicado: (2012)

Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease
por: Tate, Barbara, et al.
Publicado: (2012)

Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
por: Singh, Som, et al.
Publicado: (2022)

Biogenesis of γ-secretase early in the secretory pathway
por: Kim, Jinoh, et al.
Publicado: (2007)

Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice
por: Prinzen, Claudia, et al.
Publicado: (2009)

Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris
por: Kugelmann, Daniela, et al.
Publicado: (2022)

Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease
por: Hershkovits, Ayelet Sarah, et al.
Publicado: (2023)

ADAM10 and ADAM17: New Players in Trastuzumab Resistance
por: Duffy, Michael J., et al.
Publicado: (2014)

ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis
por: Van Meenen, Dario, et al.
Publicado: (2022)

The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007)

The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
por: Chávez-Gutiérrez, Lucía, et al.
Publicado: (2012)

Turning the tide on Alzheimer’s disease: modulation of γ-secretase
por: Luo, Joanna E., et al.
Publicado: (2022)

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
por: Matthews, Alexandra L., et al.
Publicado: (2017)

Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain
por: Gil-Bea, Francisco, et al.
Publicado: (2012)

ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?
por: Maas, Sanne L., et al.
Publicado: (2023)

Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer’s Therapeutics
por: Mouchlis, Varnavas D., et al.
Publicado: (2020)

Assessment of ADAM17 and ADAM10 proteins with CXCL10 and thyroid autoimmunity in vitiligo pathogenesis
por: Kılıc, Sevilay, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fpb2b7sbu75u5c8ll9bhfpfvtl